Lima, December 22, 2021Updated on 12/22/2021 10:40 am
The Minister of Health, Hernando Cevallos, reported that vaccination against the coronavirus (COVID-19) to children from 5 to 11 years that is scheduled to start in the first month of next year will be decentralized in the country. He recalled that the first half of January will arrive in Peru, the laboratory doses Pfizer for this age group and guarantee a safe return to school.
LOOK: COVID-19: When will the vaccination of children from 5 years begin?
During the supervision of the vaccination on the Champ de Mars (Jesús MarÃa), the official reported that it seeks to vaccinate more than 3 million minors between the months of January and February, so that in March most of them go to the educational center in person.
“Indeed, the contract with Pfizer is already closed. In the first half of January, vaccines would be arriving to immunize the 3 million 700 thousand children between 5 and 11 years of age in the country. This batch, as soon as it arrives, is going to start in a decentralized manner throughout the country. After the fortnight, children from 5 to 11 years old are vaccinated. We hope during the months of January and February to address this group of children to start classes with greater safety and avoid contagions “, Indian.
About the vaccine for minors
The General Directorate of Medicines, Supplies and Drugs (Digemid) of the Minsa authorized the use of the Pfizer laboratory vaccine against COVID-19, for him age group 5 to 11 years It will have a different presentation but the same active principle.
The Conditional Sanitary Registry of the vaccine is N ° BEC0009 – Pfizer, which is published on the Digemid web portal. Its validity is one year, renewable for the same period.
LOOK: Minsa reports that 33% of older adults already have a third dose of the COVID-19 vaccine
Likewise, the presentation of the vaccine consists of a multidose vial, which must be diluted before use. Each vial contains 1.3 milliliter (ml) and once prepared it yields 10 doses.
According to the health authorization, its administration is intramuscularly and it is recommended to administer the second dose three weeks after the first.
According to the criteria of
Know more
RECOMMENDED VIDEO
